Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Double Blind Controlled Trial Comparing the Safety and Efficacy of Apremilast Versus Placebo in Severe Forms of Recurrent Aphthous Stomatitis

NCT04227314 is registered in ClinicalTrials.gov with University Hospital, Rouen as lead sponsor.

NCT NCT04227314
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04227314 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Double Blind Controlled Trial Comparing the Safety and Efficacy of Apremilast Versus Placebo in Severe Forms of Recurrent Aphthous Stomatitis
Lead sponsor
University Hospital, Rouen
Phase
Phase 3
Overall status
Recruiting
Start date
April 10, 2022
Completion date
December 31, 2026
Enrollment
134 (estimated)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

recurrent aphtous stomatitis